S1. RAD51 and �H2AX foci in PEO1 and PEO4 cells. S2. Cisplatin and rucaparib dose responses in PEO1 and PEO4 cells. S3. dl922-947 sensitivty in PEO1 and PEO4 cells - clonogenic assays. S4. Long exposure Southern blot for adenovirus type 5 DNA in PEO1 and PEO4. S5. Ad11 and A35 cytotoxicity. S6. Baseline cell cycle status in PEO1 and PEO4 cells. S7. E2DBP and BRCA2 co-localise in TOV21G cells following dl922-947 infection. S8. RAD51 siRNA in PEO1 and PEO4 using second siRNA species. S9. RAD51 siRNA in HeLa cells. S10. RAD51 siRNA in PEO1 and PE4 cells - clonogenic assays. S11. DR-GFP following RAD51 siRNA.